Microneedle patch

DEVICE5 trials

Sponsors

Emory University, University of Iowa, Innoture Ltd, Dhurakij Pundit University, Thammasat University

Conditions

DiabetesEnlarged PoresHealthyHealthy population microneedle patch, transdermal drug delivery, wrinkle, botulinum toxinTopical Anaesthesia

Phase 1

A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity

CompletedNCT03629041

Innoture LtdTopical Anaesthesia

Start: 2018-07-31End: 2018-08-22Updated: 2019-11-14

Phase 3

A Split-Face Comparison of Novel Microneedle Patch versus Botulinum Toxin-A and Microneedle Patch for Improvement in Undereye Skin Texture

Active, not recruitingTCTR20231002007

Thammasat UniversityHealthy population microneedle patch, transdermal drug delivery, wrinkle, botulinum toxin

Start: 2022-09-22Target: 25Updated: 2026-03-30

Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

Active, not recruitingNCT06293755

Dhurakij Pundit UniversityEnlarged Pores

Start: 2024-02-28End: 2024-06-25Target: 16Updated: 2024-03-05

Unknown Phase

Glucose Measurement Using Microneedle Patches

CompletedNCT02682056

Emory UniversityDiabetes

Start: 2017-12-21End: 2018-01-29Updated: 2020-01-03

Racial/Ethnic Differences in Microneedle Response

CompletedNCT03332628

University of IowaHealthy

Start: 2018-02-01End: 2020-10-13Updated: 2021-02-15